Sienna M. Durbin

Internal Medicine

15 Parkman St Ste 635
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Assessing the relationship between event-free and overall survival in randomized controlled trials of perioperative chemoimmunotherapy in gastroesophageal cancers.

Assessing the relationship between event-free and overall survival in randomized controlled trials of perioperative chemoimmunotherapy in gastroesophageal cancers.

Journal: ESMO gastrointestinal oncology

Published: August 12, 2026

Rare Gastroesophageal Tumor Subtypes: Clinicopathologic Characteristics, Molecular Alterations, and Therapeutic Implications.

Rare Gastroesophageal Tumor Subtypes: Clinicopathologic Characteristics, Molecular Alterations, and Therapeutic Implications.

Journal: Cancers

Published: June 10, 2026

Perceptions of Prognosis and Hope Among Patients With Advanced Cancer at the Time of Enrollment in an Early-Phase Clinical Trial.

Perceptions of Prognosis and Hope Among Patients With Advanced Cancer at the Time of Enrollment in an Early-Phase Clinical Trial.

Journal: JCO oncology practice

Published: March 20, 2026

Associations of symptom burden with patient-reported outcomes and clinical outcomes among early phase cancer clinical trial participants.

Associations of symptom burden with patient-reported outcomes and clinical outcomes among early phase cancer clinical trial participants.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: September 29, 2025

Late-Onset Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy.

Late-Onset Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy.

Journal: JAMA network open

Published: March 27, 2025

Time Toxicity Experienced by Early-Phase Cancer Clinical Trial Participants.

Time Toxicity Experienced by Early-Phase Cancer Clinical Trial Participants.

Journal: JCO oncology practice

Published: June 10, 2024

Financial toxicity in early-phase cancer clinical trial participants.

Financial toxicity in early-phase cancer clinical trial participants.

Journal: Cancer

Published: May 21, 2024

Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis.

Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis.

Journal: Journal for immunotherapy of cancer

Published: June 07, 2023

Identifying Early-Phase Clinical Trial Participants at Risk for Experiencing Worse Clinical Outcomes.

Identifying Early-Phase Clinical Trial Participants at Risk for Experiencing Worse Clinical Outcomes.

Journal: JCO oncology practice

Published: February 15, 2023

Financial toxicity in cancer care: origins, impact, and solutions.

Financial toxicity in cancer care: origins, impact, and solutions.

Journal: Translational behavioral medicine

Published: December 01, 2021

Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer.

Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer.

Journal: Journal for immunotherapy of cancer

Published: July 13, 2021

Quantitative Disorder Analysis and Particle Removal Efficiency of Polypropylene-Based Masks.

Quantitative Disorder Analysis and Particle Removal Efficiency of Polypropylene-Based Masks.

Journal: MRS advances

Published: January 13, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026